144 results
Page 3 of 8
8-K
EX-1.1
48eg2om 7d
5 Aug 20
VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
9:56pm
424B5
gmgpaje9rj177avw
3 Aug 20
Prospectus supplement for primary offering
8:45pm
424B5
g30tmcn 5wb7
31 Jul 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
6crpr8gf
26 Jun 20
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
5:27pm
424B3
8pzuhzcxpq9wx3 3owue
15 May 20
Prospectus supplement
4:34pm
424B3
jj0wq8lzgu0xum2csgvd
15 Apr 20
Prospectus supplement
4:27pm
8-K
EX-10.1
8d4wrl1 glg
26 Mar 20
VistaGen Therapeutics Announces Common Stock Purchase Agreement for up to $10.25 Million
7:05am
8-K
EX-10.1
gfjq44 ynq9zxe40pz
27 Jan 20
Entry into a Material Definitive Agreement
12:00am
S-8 POS
2o2 yuwee28z
1 Oct 19
Registration of securities for employees (post-effective amendment)
12:00am